MetaADEDB 2.0 @ LMMD
Iron-Dextran Complex
(CWYNVVGOOAEACU-UHFFFAOYSA-N)
Structure
SMILES
[Fe+2]
Type(s)
Experimental
Molecular Formula:
Fe++
Molecular Weight:
55.845
Log P:
-0.0025
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
0
CAS Number(s):
15438-31-0
Synonym(s)
1.
Iron-Dextran Complex
2.
Dextran-Iron Complex
3.
Dexferrum
4.
Dextrofer
5.
Feosol
6.
Ferridextran
7.
Hematran
8.
Icar
9.
Imfergen
10.
Imferon
11.
Imperon
12.
Imposil
13.
InFed
14.
Norferan
15.
Dextran Iron Complex
16.
Iron Dextran Complex
External Link(s)
MeSHD007505
PubChem Compound27284
ChEBI29033
DrugBankDB14510
KEGGcpd:C14818
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Back PainFAERS: 15US FAERS
2NauseaFAERS: 15US FAERS
3FlushingFAERS: 11US FAERS
4Throat irritationFAERS: 10US FAERS
5VomitingFAERS: 10US FAERS
6DizzinessFAERS: 9US FAERS
7ErythemaFAERS: 9US FAERS
8HypersensitivityFAERS: 9US FAERS
9HypotensionFAERS: 9US FAERS
10Wrong technique in product usage processFAERS: 9US FAERS
11Anaphylactic shockFAERS: 8US FAERS
12Chest PainFAERS: 8US FAERS
13Product preparation errorFAERS: 8US FAERS
14AnxietyFAERS: 7US FAERS
15Cardiac ArrestFAERS: 6US FAERS
16PruritusFAERS: 6US FAERS
17Chest discomfortFAERS: 5US FAERS
18HeadacheFAERS: 5US FAERS
19PalpitationsFAERS: 5US FAERS
20Feeling abnormalFAERS: 4US FAERS
21Lip swellingFAERS: 4US FAERS
22TachycardiaFAERS: 4US FAERS
23UrticariaFAERS: 4US FAERS
24Blood pressure immeasurableFAERS: 3US FAERS
25ChillsFAERS: 3US FAERS
26DiscomfortFAERS: 3US FAERS
27ExtravasationFAERS: 3US FAERS
28FatigueFAERS: 3US FAERS
29HypoxiaFAERS: 3US FAERS
30Injection site painFAERS: 3US FAERS
31MalaiseFAERS: 3US FAERS
32TremorFAERS: 3US FAERS
33Urinary IncontinenceFAERS: 3US FAERS
34Anaphylactoid ReactionFAERS: 2US FAERS
35Depressed Level of ConsciousnessFAERS: 2US FAERS
36DiplopiaFAERS: 2US FAERS
37DisorientationFAERS: 2US FAERS
38Drug exposure during pregnancyFAERS: 2US FAERS
39Hepatic siderosisFAERS: 2US FAERS
40Oropharyngeal painFAERS: 2US FAERS
41PainFAERS: 2US FAERS
42Pharyngolaryngeal PainFAERS: 2US FAERS
43Respiratory distressFAERS: 2US FAERS
44SwellingFAERS: 2US FAERS
45WheezingFAERS: 2US FAERS
46Abdominal PainFAERS: 1US FAERS
47Administration site extravasationFAERS: 1US FAERS
48Altered state of consciousnessFAERS: 1US FAERS
49AmnesiaFAERS: 1US FAERS
50AngioedemaFAERS: 1US FAERS
51ArthralgiaFAERS: 1US FAERS
52AsthmaFAERS: 1US FAERS
53Bone painFAERS: 1US FAERS
54BradycardiaFAERS: 1US FAERS
55BronchospasmFAERS: 1US FAERS
56Burning sensationFAERS: 1US FAERS
57Carotid pulse decreasedFAERS: 1US FAERS
58Choking sensationFAERS: 1US FAERS
59CryingFAERS: 1US FAERS
60CyanosisFAERS: 1US FAERS
61Drug administration errorFAERS: 1US FAERS
62Drug monitoring procedure incorrectly performedFAERS: 1US FAERS
63Drug titration errorFAERS: 1US FAERS
64Drug toxicityFAERS: 1US FAERS
65DysgeusiaFAERS: 1US FAERS
66DyspepsiaFAERS: 1US FAERS
67Endometrial hypertrophyFAERS: 1US FAERS
68EructationFAERS: 1US FAERS
69Eye painFAERS: 1US FAERS
70Immediate post-injection reactionFAERS: 1US FAERS
71Incorrect drug administration rateFAERS: 1US FAERS
72Infusion Site ExtravasationFAERS: 1US FAERS
73Injection site bruisingFAERS: 1US FAERS
74Injection site extravasationFAERS: 1US FAERS
75Injection site injuryFAERS: 1US FAERS
76Leukocytoclastic vasculitisFAERS: 1US FAERS
77Maternal exposure during pregnancyFAERS: 1US FAERS
78Medication ErrorFAERS: 1US FAERS
79Metabolic acidosisFAERS: 1US FAERS
80MiliariaFAERS: 1US FAERS
81Musculoskeletal discomfortFAERS: 1US FAERS
82MyalgiaFAERS: 1US FAERS
83Myocardial InfarctionFAERS: 1US FAERS
84Occult blood positiveFAERS: 1US FAERS
85Oxygen saturation increasedFAERS: 1US FAERS
86PallorFAERS: 1US FAERS
87PeritonitisFAERS: 1US FAERS
88Product administered at inappropriate siteFAERS: 1US FAERS
89Product administration errorFAERS: 1US FAERS
90Product closure issueFAERS: 1US FAERS
91Product formulation issueFAERS: 1US FAERS
92Product preparation issueFAERS: 1US FAERS
93Product quality issueFAERS: 1US FAERS
94Product storage errorFAERS: 1US FAERS
95Renal tubular necrosisFAERS: 1US FAERS
96Respiratory DepressionFAERS: 1US FAERS
97Respiratory FailureFAERS: 1US FAERS
98Respiratory arrestFAERS: 1US FAERS
99RestlessnessFAERS: 1US FAERS
100RhinitisFAERS: 1US FAERS
101Serum SicknessFAERS: 1US FAERS
102SneezingFAERS: 1US FAERS
103SomnolenceFAERS: 1US FAERS
104Stevens-Johnson SyndromeFAERS: 1US FAERS
105StillbirthFAERS: 1US FAERS
106StressFAERS: 1US FAERS
107StridorFAERS: 1US FAERS
108SyncopeFAERS: 1US FAERS
109Toxic Epidermal NecrolysisFAERS: 1US FAERS
110Unresponsive to stimuliFAERS: 1US FAERS
111Wrong technique in drug usage processFAERS: 1US FAERS
112nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.